Versartis Inc. Report issue

For profit Phase 3
Founded: Menlo PArk CA United States (2008)
Status: Acquired by Aravive Biologics (2018)

Organization Overview

First Clinical Trial
2011
NCT01359488
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 3 Trials (2)

somatropin (protropin) (1 trial)

somavaratan (8 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Dwarfism, Pituitary (Phase 3)

Endocrine System Diseases (Phase 3)

Growth Disorders (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 2